Bunkerhill ECG-EF vs EchoGo® Heart Failure
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Bunkerhill ECG-EF leverages AI to detect reduced Left Ventricular Ejection Fraction (HFrEF) from routine ECGs, serving as an early identification tool for patients at risk of heart failure. In contrast, Ultromics' EchoGo® Heart Failure analyzes echocardiograms to diagnose Heart Failure with preserved Ejection Fraction (HFpEF), offering detailed insights for clinical decision-making. While both are FDA-cleared AI solutions for heart failure, they differ significantly in their input data and the specific heart failure phenotype they target.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Bunkerhill ECG-EF (Tool A) detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in the early identification of patients at risk for heart failure with reduced ejection fraction (HFrEF). EchoGou00ae Heart Failure (Tool B) specifically analyzes routine echocardiograms to detect heart failure with preserved ejection fraction (HFpEF).
Bunkerhill ECG-EF (Tool A) analyzes routine 12-lead electrocardiogram (ECG) data. EchoGou00ae Heart Failure (Tool B) analyzes routine echo video clips from echocardiograms.
Bunkerhill ECG-EF (Tool A) integrates seamlessly with Electronic Health Records (EHRs) and clinical archives as a software-only medical device. EchoGou00ae Heart Failure (Tool B) is a cloud-based platform that integrates seamlessly with existing workflows and IT stacks, utilizing a DICOM workflow for report delivery to PACS.
For Bunkerhill ECG-EF (Tool A), pricing requires direct contact, and no specific reimbursement information is provided in the given facts. EchoGou00ae Heart Failure (Tool B) is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers.
Bunkerhill ECG-EF (Tool A) is described as a non-invasive, rapid, and accessible cardiac diagnostic tool, though a specific turnaround time is not stated. EchoGou00ae Heart Failure (Tool B) delivers insights within 20 minutes of analyzing routine echo video clips.
Both Bunkerhill ECG-EF (Tool A) and EchoGou00ae Heart Failure (Tool B) are FDA-cleared artificial intelligence algorithms. EchoGou00ae Heart Failure (Tool B) is additionally clinically validated with 90% sensitivity and 86% specificity for HFpEF, trained on over 10 years of outcome data.
Bunkerhill ECG-EF (Tool A) aids in the early identification of patients at risk for heart failure by detecting reduced LVEF from routine ECGs, supporting automated clinical workflows. EchoGou00ae Heart Failure (Tool B) provides AI-powered HFpEF detection and insights within 20 minutes to support clinical decisions, offering automated structured reports.